These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6501905)

  • 41. Influenza and pneumococcal vaccination rates among persons with diabetes mellitus--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Oct; 48(42):961-7. PubMed ID: 10553810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations--United States, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Oct; 48(39):886-90. PubMed ID: 10550040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics and Differences in Pneumococcal Vaccines: 1. Polysaccharide vaccine].
    Maruyama T
    Nihon Naika Gakkai Zasshi; 2015 Nov; 104(11):2314-23. PubMed ID: 28520389
    [No Abstract]   [Full Text] [Related]  

  • 44. Pneumococcal vaccination. Controversies and opportunities.
    Spika JS; Fedson DS; Facklam RR
    Infect Dis Clin North Am; 1990 Mar; 4(1):11-27. PubMed ID: 2407776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination against pneumococcal infection.
    Noah ND
    BMJ; 1988 Nov; 297(6660):1351-2. PubMed ID: 3146360
    [No Abstract]   [Full Text] [Related]  

  • 46. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Loubet P; Kernéis S; Groh M; Loulergue P; Blanche P; Verger P; Launay O
    Vaccine; 2015 Jul; 33(31):3703-8. PubMed ID: 26073016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
    Chan TC; Hung IF; Luk JK; Shea YF; Chan FH; Woo PC; Chu LW
    J Am Med Dir Assoc; 2012 Oct; 13(8):698-703. PubMed ID: 22722051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children.
    Douglas RM; Miles HB
    J Infect Dis; 1984 Jun; 149(6):861-9. PubMed ID: 6376653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACIP updates recommendations for pneumococcal vaccine.
    Am Fam Physician; 1989 May; 39(5):386, 388. PubMed ID: 2610197
    [No Abstract]   [Full Text] [Related]  

  • 50. Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Jul; 44(27):506-7, 513-5. PubMed ID: 7596336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two Randomized Trials of the Effect of Live Attenuated Influenza Vaccine on Pneumococcal Colonization.
    Rylance J; de Steenhuijsen Piters WAA; Mina MJ; Bogaert D; French N; Ferreira DM;
    Am J Respir Crit Care Med; 2019 May; 199(9):1160-1163. PubMed ID: 30758980
    [No Abstract]   [Full Text] [Related]  

  • 52. Emergency department immunization of the elderly with pneumococcal and influenza vaccines.
    Rodriguez RM; Baraff LJ
    Ann Emerg Med; 1993 Nov; 22(11):1729-32. PubMed ID: 8214864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
    Xu Q; Pryharski K; Pichichero ME
    Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines.
    Çiftci F; Şen E; Demir N; Çiftci O; Erol S; Kayacan O
    Hum Vaccin Immunother; 2018 Jan; 14(1):111-117. PubMed ID: 29049005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumococcal vaccine response in human immunodeficiency virus-infected patients.
    Swiatlo E; Benton K; Briles DE
    J Infect Dis; 1996 Mar; 173(3):777-8. PubMed ID: 8627053
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
    Blumberg EA; Brozena SC; Stutman P; Wood D; Phan HM; Musher DM
    Clin Infect Dis; 2001 Jan; 32(2):307-10. PubMed ID: 11170924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.
    Honkanen PO; Keistinen T; Miettinen L; Herva E; Sankilampi U; Läärä E; Leinonen M; Kivelä SL; Mäkelä PH
    Vaccine; 1999 Jun; 17(20-21):2493-500. PubMed ID: 10418894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospects for an emergency department-based adult immunization program.
    Polis MA; Smith JP; Sainer D; Brenneman MN; Kaslow RA
    Arch Intern Med; 1987 Nov; 147(11):1999-2001. PubMed ID: 3675103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza vaccination and warfarin anticoagulation.
    Lipsky BA; Pecoraro RE; Roben NJ; de Blaquiere P; Delaney CJ
    Ann Intern Med; 1984 Jun; 100(6):835-7. PubMed ID: 6721299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years.
    Schwarz TF; Schmoele-Thoma B
    Vaccine; 2013 Jan; 31(2):291-4. PubMed ID: 23123107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.